Ruiqi Liu

761 total citations · 1 hit paper
22 papers, 553 citations indexed

About

Ruiqi Liu is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Ruiqi Liu has authored 22 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Nephrology. Recurrent topics in Ruiqi Liu's work include Inflammasome and immune disorders (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Peptidase Inhibition and Analysis (2 papers). Ruiqi Liu is often cited by papers focused on Inflammasome and immune disorders (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Peptidase Inhibition and Analysis (2 papers). Ruiqi Liu collaborates with scholars based in China, Romania and Netherlands. Ruiqi Liu's co-authors include Guofan Qu, Yunjing Hou, Di Zhao, Zhao Liu, Xinxin Yang, Hongxue Meng, Chenxu Guo, Viola Klück, Leo A. B. Joosten and Melvin L.K. Chua and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ruiqi Liu

20 papers receiving 546 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles

2020 267 citations Yunjing Hou, Xinxin Yang et al. International Journal of Nanomedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruiqi Liu China	8	226	179	139	120	76	22	553
Qian Shao China	12	109 0.5×	125 0.7×	122 0.9×	88 0.7×	48 0.6×	55	559
Dinesh Doval India	10	87 0.4×	218 1.2×	179 1.3×	200 1.7×	33 0.4×	32	514
Xing‐Chun Peng China	17	190 0.8×	306 1.7×	228 1.6×	139 1.2×	54 0.7×	34	740
Wojciech Latos Poland	15	309 1.4×	81 0.5×	358 2.6×	47 0.4×	103 1.4×	37	570
Jinlong Tong China	11	185 0.8×	344 1.9×	138 1.0×	63 0.5×	54 0.7×	16	603
Luo‐Wei Wang China	15	248 1.1×	223 1.2×	416 3.0×	318 2.6×	102 1.3×	58	944
Xiaojiao Zeng China	10	42 0.2×	141 0.8×	66 0.5×	110 0.9×	45 0.6×	20	395
Cong Jiang China	13	103 0.5×	205 1.1×	60 0.4×	108 0.9×	78 1.0×	34	462
Guoqing Sui China	18	162 0.7×	251 1.4×	69 0.5×	51 0.4×	45 0.6×	45	863

Countries citing papers authored by Ruiqi Liu

Since Specialization

Citations

This map shows the geographic impact of Ruiqi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiqi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiqi Liu more than expected).

Fields of papers citing papers by Ruiqi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiqi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiqi Liu. The network helps show where Ruiqi Liu may publish in the future.

Co-authorship network of co-authors of Ruiqi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiqi Liu. A scholar is included among the top collaborators of Ruiqi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiqi Liu. Ruiqi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Ruiqi, et al.. (2025). Dioscin regulates oxidative stress and autophagy in uric acid-induced HK-2 cells through the P62-KEAP1-NRF2 signaling pathway. BMC Nephrology. 26(1). 422–422. 1 indexed citations

Liu, Ruiqi, et al.. (2024). Ginsenoside Rg1 Induces Autophagy in Colorectal Cancer through Inhibition of the Akt/mTOR/p70S6K Pathway. Journal of Microbiology and Biotechnology. 34(4). 774–782. 4 indexed citations

Liu, Ruiqi, Leo A. B. Joosten, Ioan Pop, et al.. (2024). GWAS-identified hyperuricemia-associated IGF1R variant rs6598541 has a limited role in urate mediated inflammation in human mononuclear cells. Scientific Reports. 14(1). 3565–3565.

Huang, Tingxuan, Yulu Peng, Ruiqi Liu, et al.. (2024). Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy. International Immunopharmacology. 142(Pt B). 113106–113106. 3 indexed citations

Liu, Ruiqi, et al.. (2024). Tanshinone IIA Regulates NRF2/NLRP3 Signal Pathway to Restrain Oxidative Stress and Inflammation in Uric Acid-Induced HK-2 Fibrotic Models. Endocrine Metabolic & Immune Disorders - Drug Targets. 25(9). 721–731. 4 indexed citations

Wang, Lin, Jinxiang Wang, Guorong Fan, et al.. (2024). The effect and mechanism of Fushen Granule on gut microbiome in the prevention and treatment of chronic renal failure. Frontiers in Cellular and Infection Microbiology. 13. 1334213–1334213. 8 indexed citations

Liu, Chao, Rui Huang, Lin Fang, et al.. (2024). Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study. Cancer Immunology Immunotherapy. 73(8). 159–159. 1 indexed citations

Liu, Ruiqi, Viola Klück, Brenda Kischkel, et al.. (2024). Soluble urate-induced effects on cytokine production in vitro – Assessment of methodologies and cell types. Cytokine. 175. 156502–156502. 1 indexed citations

Wang, Ranran, Dewen Kong, Ruiqi Liu, et al.. (2023). Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy. Biomedicine & Pharmacotherapy. 160. 114382–114382. 17 indexed citations

10.

Liu, Ruiqi. (2023). The Effects of Population Aging on GDP. Advances in Economics Management and Political Sciences. 26(1). 279–285.

11.

Wu, Teng, Ming Kong, Ruiqi Liu, et al.. (2022). Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis. Thrombosis Research. 219. 121–132. 5 indexed citations

12.

Liu, Ruiqi, Ming Pei, Qihang Su, et al.. (2021). Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGFβ1/ BMP7 / Gremlin1/ Smad Pathway. Frontiers in Pharmacology. 12. 628671–628671. 7 indexed citations

13.

Liu, Ruiqi, Guonian Zhu, Li Fu, et al.. (2021). NETs promote pathogenic cardiac fibrosis and participate in ventricular aneurysm formation after ischemia injury through the facilitation of perivascular fibrosis. Biochemical and Biophysical Research Communications. 583. 154–161. 14 indexed citations

14.

Zhang, Lele, Jun Lü, Ruiqi Liu, et al.. (2020). Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells. Acta Pharmacologica Sinica. 41(10). 1357–1365. 25 indexed citations

15.

Hou, Yunjing, Xinxin Yang, Ruiqi Liu, et al.. (2020). Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles. International Journal of Nanomedicine. Volume 15. 6827–6838. 267 indexed citations breakdown →

16.

Klück, Viola, Ruiqi Liu, & Leo A. B. Joosten. (2020). The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine. 88(2). 105092–105092. 55 indexed citations

17.

Meng, Hongxue, Xinxin Yang, Ruiqi Liu, et al.. (2020). The Relationship Between Human Papillomavirus, OFD1 and Primary Ciliogenesis in the Progression of Oropharyngeal Cancer: A Retrospective Cohort Study. Pharmacogenomics and Personalized Medicine. Volume 13. 633–644. 5 indexed citations

18.

Lv, Jia‐Wei, Yu‐Pei Chen, Guan‐Qun Zhou, et al.. (2019). Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nature Communications. 10(1). 3941–3941. 111 indexed citations

19.

Liang, Li, Jiawen Tian, Yiyi Yu, et al.. (2018). An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients. Cellular Physiology and Biochemistry. 50(2). 768–782. 7 indexed citations

20.

Xu, Fei, Ruiqi Liu, Rong Cao, et al.. (2017). Perioperative plasma mitochondrial DNA dynamics and correlation with inflammation during infantile cardiopulmonary bypass. Indian Heart Journal. 69(6). 797–800. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact